DUBLIN, Dec. 9, 2025 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced it ...
ProVerum has closed an $80m Series B equity financing round, boosting commercialisation efforts for its ProVee system for benign prostatic hyperplasia (BPH). The funding round was led by MVM Partners, ...
DUBLIN, March 20, 2024 /PRNewswire/ -- ProVerum Limited, an Irish medical device company developing a minimally invasive solution to treat benign prostatic hyperplasia (BPH) in the doctor's office, ...
En este evento, a realizarse el próximo 23 de octubre en el LABNL, las y los asistentes podrán conocer de voz de los expertos, todo sobre los procesos de compra pública, desde cómo registrarse en el ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results